Cargando…
First, Do No Harm: Caution Against Use of Tocilizumab in COVID-19
Autor principal: | Mastroianni, Fiore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640891/ https://www.ncbi.nlm.nih.gov/pubmed/33160536 http://dx.doi.org/10.1016/j.chest.2020.06.052 |
Ejemplares similares
-
Caution against corticosteroid-based COVID-19 treatment
por: Tang, Chong, et al.
Publicado: (2020) -
WHO prequalified tocilizumab and vaccine boosters against COVID-19
por: Rahimi, Farid, et al.
Publicado: (2022) -
COVID-19, ECMO, and lymphopenia: a word of caution
por: Henry, Brandon Michael
Publicado: (2020) -
Caution When Comparing the Impact of Corticosteroids in COVID-19
por: Confalonieri, Marco, et al.
Publicado: (2021) -
Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management
por: Heskin, Joseph, et al.
Publicado: (2022)